Avantor, Inc.

AVTR Healthcare Medical Instruments & Supplies

Avantor, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $6.6 billion, down 3.41% from fiscal 2024.

Revenue
+4.59%
EPS
+128.9%
Free cash flow
−9.03%
Total debt
−4.51%

Quarter to September 2026, against a year earlier

15.14 0.51 −3.26%
Market cap
$10.3B
P/E
30.3×
Fwd P/E
34.8×
Dividend yield
—
F-score
4/9
Altman Z
1.55
Beneish M
−2.91
Dividend safety
n/a

Avantor, Inc. (AVTR) Total debt

Alert me on Total debt

Avantor, Inc.'s total debt at the end of fiscal 2025 was $3.9B, unchanged from fiscal 2024. At the end of the quarter to 30 September 2026 it was $3.7B. Over the past ten years it has ranged from $1.3B (fiscal 2016) to $7.1B (fiscal 2017); the current reading is higher than 20% of that period. Avantor, Inc. ranks 6th of 50 Medical Instruments & Supplies companies by total debt.

Total debt, annual

Embed this chart

Annual newest first

Period Total debt Change
FY2025 $3.9B (2.70%)
FY2024 $4.1B (26.75%)
FY2023 $5.5B (11.94%)
FY2022 $6.3B (10.48%)
FY2021 $7.0B 43.51%
FY2020 $4.9B (4.35%)
FY2019 $5.1B (26.11%)
FY2018 $6.9B (2.72%)
FY2017 $7.1B 449.23%
FY2016 $1.3B —

Quarterly newest first

Period Total debt Change
Sep 2026 $3.7B (0.38%)
Jun 2026 $3.7B (3.11%)
Mar 2026 $3.8B (3.29%)
Dec 2025 $3.9B 2.29%
27 more quarters

Against its own ten years

Low $1.3B High $7.1B
Ten-year median $5.3B
Current reading's percentile 20

Total debt against peers

What Total debt is

Total Debt tells an investor how much a company has borrowed in all, whether the money is due within a year or later.

Long Term Debt (Total) + Current Part of Debt

The full definition of Total debt →

More on AVTR